ArticleTherapeutic advances in gastroenterology2020

Biomarkers are associated with clinical and endoscopic outcomes with vedolizumab treatment in Crohn's disease.

Ariela K Holmer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.